Lupin is currently trading at Rs. 586.10, up by 3.95 points or 0.68% from its previous closing of Rs. 582.15 on the BSE.
The scrip opened at Rs. 590.75 and has touched a high and low of Rs. 593.85 and Rs. 580.00 respectively. So far 40,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 593.85 on 24-Jul-2012 and a 52 week low of Rs. 409.50 on 14-Dec-2011.
Last one week high and low of the scrip stood at Rs. 593.85 and Rs. 563.20 respectively. The current market cap of the company is Rs. 26,180 crore.
The promoters holding in the company stood at 46.91% while Institutions and Non-Institutions held 43.97% and 9.12% respectively.
On standalone basis, the company has posted a rise of 391.04% in its net profit at Rs 357.23 crore for the quarter ended June 30, 2012 as compared to Rs 72.75 crore for the same quarter in the previous year. Total income has increased by 61.01% at Rs 1780.29 crore for quarter under review as compared to Rs 1105.71 crore for the quarter ended June 30, 2011.
On consolidated basis, the company has posted a rise of 33.47% in its net profit at Rs 280.39 crore for the quarter ended June 30, 2012 as compared to Rs 210.08 crore for the same quarter in the previous year. Total income has increased by 43.78% at Rs 2253.74 crore for quarter under review as compared to Rs 1567.53 crore for the quarter ended June 30, 2011.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1814.50 |
Dr. Reddys Lab | 1340.80 |
Cipla | 1476.45 |
Lupin | 2160.20 |
Zydus Lifesciences | 972.95 |
View more.. |